These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30467732)

  • 21. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA.
    Mühlbacher AC; Kaczynski A
    Appl Health Econ Health Policy; 2016 Feb; 14(1):29-40. PubMed ID: 26519081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multi-criteria decision approach for ranking unmet needs in healthcare.
    Cleemput I; Devriese S; Kohn L; Westhovens R
    Health Policy; 2018 Aug; 122(8):878-884. PubMed ID: 29983193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).
    Wahlster P; Goetghebeur M; Kriza C; Niederländer C; Kolominsky-Rabas P;
    BMC Health Serv Res; 2015 Jul; 15():262. PubMed ID: 26152122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets.
    Brixner D; Kaló Z; Maniadakis N; Kim K; Wijaya K
    Value Health Reg Issues; 2018 Sep; 16():9-13. PubMed ID: 29605800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinoembryonic antigen (CEA) levels in hookah smokers, cigarette smokers and non-smokers--a comment.
    Maziak W
    J Pak Med Assoc; 2008 Mar; 58(3):155. PubMed ID: 18517128
    [No Abstract]   [Full Text] [Related]  

  • 27. Health Technology Assessment and Appraisal of Therapies for Rare Diseases.
    Iskrov G; Miteva-Katrandzhieva T; Stefanov R
    Adv Exp Med Biol; 2017; 1031():221-231. PubMed ID: 29214575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage?
    Kawachi R; Nakazato Y; Takei H; Koshi-ishi Y; Goya T
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):199-202. PubMed ID: 19457896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Involving patients, the insured and the general public in healthcare decision making].
    Mühlbacher AC; Juhnke C
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():36-44. PubMed ID: 26875034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Correlation with plasma carcinoembryonic antigen levels.
    Hamada Y; Yamamura M; Hioki K; Yamamoto M; Nagura H; Watanabe K
    Cancer; 1985 Jan; 55(1):136-41. PubMed ID: 3880653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of carcinoembryonic antigen from a human colon adenocarcinoma cell line. II. Use of monoclonal antibodies to carcinoembryonic antigen for antigen purification and characterization.
    Epstein N; Zandani R; Inbar I; Altbaum Z; Lazar A; Reuveny S; Geva J; Marcus D; Mizrahi A; Ariel N
    Dev Biol Stand; 1987; 66():429-37. PubMed ID: 3556272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific adhesion of carcinoembryonic antigen-bearing colorectal cancer cells to immobilized carcinoembryonic antigen.
    Levin LV; Griffin TW
    Cancer Lett; 1991 Nov; 60(2):143-52. PubMed ID: 1657369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Support for biomedical equipment decision making.
    Shaffer MD; Shaffer MJ
    Biomed Instrum Technol; 1995; 29(3):193-201. PubMed ID: 7613566
    [No Abstract]   [Full Text] [Related]  

  • 34. Guidance toward the implementation of multicriteria decision analysis framework in developing countries.
    Inotai A; Nguyen HT; Hidayat B; Nurgozhin T; Kiet PHT; Campbell JD; Németh B; Maniadakis N; Brixner D; Wijaya K; Kaló Z
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):585-592. PubMed ID: 30092151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological heterogeneity of carcinoembryonic antigen: purification from meconium of an antigen related to carcinoembryonic antigen.
    Primus FJ; Freeman JW; Goldenberg DM
    Cancer Res; 1983 Feb; 43(2):679-85. PubMed ID: 6401222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoembryonic antigen in retinoblastoma. An immunohistochemical study.
    Kivelä T; Tarkkanen A
    Graefes Arch Clin Exp Ophthalmol; 1983; 221(1):8-11. PubMed ID: 6357957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of blood group H antigen on a carcinoembryonic antigen, and its enzymatic modification into blood group A and B specificities.
    Bali JP; Magous R; Lecou C; Mousseron-Canet M
    Cancer Res; 1976 Jul; 36(7 PT 1):2124-9. PubMed ID: 58713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prioritisation of specialist health care services; not NICE, not easy but it can be done.
    Anderson P; Webb P; Groves S
    Health Policy; 2017 Sep; 121(9):978-985. PubMed ID: 28797706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoembryonic antigen as an adhesion molecule.
    Krop-Watorek A; Lisowska E
    Arch Immunol Ther Exp (Warsz); 1998; 46(3):129-36. PubMed ID: 9704144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.